SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-204228
Filing Date
2018-06-26
Accepted
2018-06-26 17:25:06
Documents
5
Period of Report
2018-06-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d613156d8k.htm 8-K 18245
2 EX-3.1 d613156dex31.htm EX-3.1 26095
3 EX-3.2 d613156dex32.htm EX-3.2 156345
4 EX-99.1 d613156dex991.htm EX-99.1 5547
5 GRAPHIC g613156kezarlogo.jpg GRAPHIC 4674
  Complete submission text file 0001193125-18-204228.txt   214018
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38542 | Film No.: 18920115
SIC: 2834 Pharmaceutical Preparations